Suchergebnisse - "Brugés, Ricardo"

PubPharm (5)

1

Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Moehler, M. | Xiao, H. | Blum, S. | +21

2

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

enthalten in: Nature | 2022

von Shitara, K. | Ajani, J. | Moehler, M. | +26

3

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

enthalten in: The New England journal of medicine | 2022

von Schmid, P. | Cortes, J. | Dent, R. | +128

CommentIn: Nat Rev Clin Oncol. 2022 Apr;19(4):220. - PMID 35217781

4

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2021

von Janjigian, Y. | Shitara, K. | Moehler, M. | +26

CommentIn: Lancet. 2021 Jul 3;398(10294):2-3. - PMID 34102138

5

Pembrolizumab for Early Triple-Negative Breast Cancer

enthalten in: The New England journal of medicine | 2020

von Schmid, P. | Cortes, J. | Pusztai, L. | +119

CommentIn: Nat Rev Clin Oncol. 2020 Apr;17(4):196. - PMID 32127649

1
[1]